Related Experiment Video
Updated: Jun 3, 2026

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
A Cell-Cell Fusion Assay to Monitor HIV-1 Env Interactions with Chemokine Receptors
1Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pa.
Abstract:
Biological membrane fusion is an important part of many cellular processes and is a critical step in the entry of enveloped viruses, such as HIV-1, into cells. For HIV-1 to infect cells, the virus must bind to the cell surface, after which the viral Env protein must be triggered to undergo a conformational change that mediates membrane fusion. Cell-surface binding has long been known to occur via a high-affinity interaction between Env and CD4. However, the cell-surface molecules responsible for triggering the fusion-inducing conformational change in the Env protein have been only recently identified, permitting the study of HIV-1 Env-mediated membrane fusion in much greater detail (for review, see 1). These molecules, termed coreceptors, have been shown to be members of the nine-transmembrane domain receptor family. The most important HIV-1 coreceptors are the chemokine receptors CCR5 and CXCR4 (2-7), although at least nine other chemokine receptors or orphan receptors have been shown to support cellular entry for subsets of HIV-1 or SIV strains (3,5,8-11). The ability of a given virus strain to utilize particular chemokine receptors is a major determinant of cellular tropism. Thus, it is desirable to identify the receptors used by virus strains in a rapid, quantitative, and reproducible manner.

